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Abstract 
Aim: In the research and treatment of Substance Use Disorders (SUDs), craving for alcohol, 
nicotine, and drugs is an important concept associated with addictive processes, including 
relapse after treatment. The 12-item Mannheimer Craving Scale (MaCS) has been proved to be 
an economic, reliable, and valid self-rating instrument across several substances in German 
samples. The aim of this study was to examine its psychometric characteristics in a Swiss 
German sample. Method: Overall, 166 patients were recruited from an inpatient SUD treatment 
program at the University Hospital of Psychiatry in Bern, Switzerland. Results: The internal 
consistency was high and the test-retest reliability was satisfactory. The total scale and three 
specific analogue craving measures were highly correlated. Principal component analysis 
extracted two factors, explaining 61% of the total variance, and these factors were confirmed 
through confirmatory factor analysis. However, the two factors correlated highly, and several 
items loaded on both factors, so that the factor structure was inconclusive. Conclusions: The 
psychometric characteristics of the MaCS in a Swiss German sample are as good as those 
characteristics of the German version, suggesting that it is a valid and reliable measure. The 
MaCS factor structure must be examined on a larger sample that integrates a broader range of 
SUD severity. 
 
Keywords: Craving, MaCS, questionnaire, factor structure, psychometric characteristics 
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Zusammenfassung 
Ziel: Für das Verständnis von allen Störungen durch Substanzkonsum ist Suchtdruck ein 
wichtiges Konzept. Die 12 Items umfassende Mannheimer Craving Scale (MaCS) erwies sich in 
deutschen Stichproben als ökonomische, reliable und valide Selbstbeurteilungsskala 
allgemeinen Suchtdrucks. Das Ziel der Studie ist, deren psychometrischen Eigenschaften in 
einem deutschschweizerischen Patientenkollektiv zu überprüfen. Methode: In zwei Programmen 
für den qualifizierten Entzug von Substanzkonsumstörungen der Universitätsklinik für 
Psychiatrie und Psychotherapie Bern wurden bei 166 Patienten neben der MaCS auch 
soziodemographische und klinische Merkmalen erhoben. Ergebnisse: Die interne Konsistenz 
der MaCS war hoch und die Retest-Reliabilität befriedigend. Die explorative 
Hauptkomponentenanalyse extrahierte zwei Faktoren, die 61% der Gesamtvarianz erklärten und 
die in der konfirmatorischen Faktoranalyse bestätigt wurden. Die beiden Faktoren korrelierten 
stark miteinander und mehrere Items luden auf beiden Faktoren so hoch, dass die Faktorstruktur 
nicht schlüssig war. Schlussfolgerung: Die psychometrischen Eigenschaften der MaCS sind in 
Deutschland und der Schweiz ähnlich, so dass für beide Länder ein valides und reliables 
Instrument vorliegt. Die Faktorenstruktur muss in einer grösseren Stichprobe mit einem 
breiteren Spektrum an Substanzkonsumstörungen geprüft werden. 
 
Schlüsselworte: Suchtdruck, MaCS, Fragebogen, Faktorenstruktur, Psychometrische Merkmale 
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Swiss Study to Validate the Mannheimer Craving Scale (MaCS) 
 
1. Introduction 
“Alcohol is a valued product which has provided important functions for people 
throughout all history” (Hanson, 1995, p. 1). Peele and Brodsky (2000) reported in a review that 
there are positive effects of moderate alcohol use (e.g., enhancement of mood, sociability, and 
social integration). However, alcohol is also attributable to about 3.8% of all early deaths 
globally (Rehm et al., 2009), and 7.5% of people residing in Europe have been diagnosed with 
an Alcohol Use Disorder (AUD; World Health Organization, 2014a). 
A core concept in understanding Alcohol Use Disorders (AUD) is craving (Soyka & 
Küfner, 2008), which is defined as “a strong desire or urge to use alcohol” (American 
Psychiatric Association, 2013, p. 491). Craving is primarily a subjective experience (Anton, 
1999), but still a multidimensional construct, modulated by individual differences and 
environmental context (Skinner & Aubin, 2010). Craving is linked to the amount of alcohol 
consumption and risk of relapse after treatment (Drobes & Thomas, 1999). Bottlender and 
Soyka (2004) reported in a prospective study that strong craving predicts relapse in abstinent 
alcohol-dependent patients. Tiffany, Carter, and Singleton (2000) reported that craving was 
measured only by one item in several important studies on pharmacological interventions for 
alcohol dependence, making it impossible to calculate a scale’s reliability. One item also limits 
the extent to which one can detect correlational or experimental effects of craving and alcohol 
outcomes. According to Sayette et al. (2000), it is theoretically and clinically imperative to 
measure craving with valid and reliable instruments. 
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The Obsessive Compulsive Drinking Scale (OCDS) is a well-established, 14-item self-
report instrument for measure craving, developed by Anton, Moak, and Latham (1995, 1996); 
the measure has also been validated in Germany (Mann & Ackermann, 2000; Nakovics, Diehl, 
Croissant, & Mann, 2008) and Switzerland (Burren, Wapp, Seitz, Ballinari, & Moggi, 2012). 
The OCDS is an adapted and modified version of the Yale-Brown Obsessive Compulsive Scale 
for heavy drinking (Y-BOCS-hd; Modell, Glaser, Mountz, Schmaltz, & Cyr, 1992), which is 
based on the Yale-Brown Obsessive Compulsive Scale (Y-BOCS; Goodman, Price, Rasmussen, 
Mazure, Delgado, et al., 1989; Goodman, Price, Rasmussen, Mazure, Fleischmann, et al., 1989), 
a rating instrument for obsessive-compulsive disorders (OCD; World Health Organization, 
2014b). In a review, Anton (2000) concluded that the OCDS can be seen as a valid outcome 
measure as well as a valuable predictive and diagnostic tool. 
There are reliable and validated substance-specific instruments available for drugs other 
than alcohol; for example, the Cocaine Craving Questionnaire (CCQ; Tiffany, Singleton, 
Haertzen, & Henningfield, 1993), Heroin Craving Questionnaire (HCQ; Tiffany, Fields, 
Singleton, Haertzen, & Henningfield, 1993), Benzodiazepine Questionnaire (BCQ; Mol et al., 
2003), and the Short Form of the Marijuana Craving Questionnaire (MCQ-SF; Heishman et al., 
2009). However, some clinical and research situations require information on use of multiple 
substances, such as alcohol and nicotine addiction, a common comorbidity, with more than 80% 
of alcohol-dependent patients also smoking (Batel, Pessione, Maitre, & Rueff, 1995; Donath et 
al., 2007). 
Because of this lack of reliable and valid instruments for craving across several 
substances, Nakovics, Diehl, Geiselhart, and Mann (2009) adapted and validated the 
Mannheimer Craving Scale (MaCS) to the language-specific craving behaviors based on the 
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OCDS (Anton et al., 1995, 1996). The MaCS assesses overall craving across several substances, 
proving appropriate to measure multiple substance abuse. The MaCS showed high reliability 
coefficients (.87 <  < .93), with test-retest-reliability values of .45 < rtt < .68; its total score 
correlated significantly with three analogue scales for the intensity of craving (r = .56), 
maximum craving (r = .59), and frequency of craving (r = .54). 
Nonetheless, the psychometric characteristics of the MaCS have never been tested in the 
German speaking part of Switzerland, despite the fact that SUD habits might vary across these 
countries, as well as factors that might or might not impact these indices. The present study 
examines the psychometric characteristics of the MaCS in a Swiss German sample undergoing 
residential treatment for Substance Use Disorder (SUD); these include reliability, convergent 
and discriminant validity, and the factor structure (principal component analysis and 
confirmatory factor analysis). The present work extends the use of the MaCS to a broader 
German-speaking population of patients with SUD. 
 
2. Materials and Methods 
2.1 Participants 
This study was executed at the University Hospital of Psychiatry and Psychotherapy in 
Bern, a facility that offers two residential treatment programs for SUD patients. Based on the 
inclusion criteria (see Procedure), 202 patients were invited to participate from 2014 to 2015. Of 
these, 12 (5.9%) did not meet the ICD-10 criteria for an SUD (World Health Organization, 
2014b, p. 114) and 24 (11.9%) withdrew informed consent so that they needed to be excluded. 
In total, 166 (82.2%) patients were included in the study and gave written informed consent. The 
study was conducted according to the Swiss Human Research Act (HRA; Swiss Federal Council 
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2014). All participants understood and spoke German and had been clinically diagnosed with an 
SUD at admission, according to the ICD-10 (World Health Organization, 2014b, p. 114). On 
average, patients were 43.2 years old (SD = 11.6), with an age range of 18 to 65 years. Of these 
patients, 59% were men (n = 98) and 41% women (n = 68). For further demographic 
characteristics, see Table 1. 
The center requires patients to completely abstain from all substances, with the 
exception of nicotine and caffeine, and to not take prescribed medication during treatment. 
Regular drug tests are performed and any substance use results in withdrawal of permission to 
go out or discharge from the program. Patients left the center for scheduled appointments (e.g., 
appointments with psychologists or social workers). The center offers a standard inpatient 
treatment for SUD (e.g., psychotherapy, physiotherapy, music therapy), according to an 
individualized treatment schedule. A typical treatment lasts between three and six weeks, 
offering the option to participate in an additional outpatient treatment program for aftercare 
(Wittchen & Hoyer, 2011). 
2.2 Procedure 
The data for this study were obtained from an observational Quality Management study, 
an ongoing longitudinal naturalistic cohort study on the course of SUD, which started in April 
2014. The inclusion criteria for participants were as follows: (1) to have the ability to give 
informed, voluntary and written consent to participate, (2) to be an inpatient in the hospital 
wards for SUD, (3) to have the language skills to understand and answer the questions in 
German, (4) to have the cognitive competence and ability to complete the assessment, and (5) to 
be aged between 18 and 65 years. The assessment took place three times a week, in a separate, 
quiet testing room, lasting 30 to 90 minutes. In each case, a psychologist led the assessment and 
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explained the procedure. Patients completed the first assessment within seven days after 
admission and the second assessment within seven days prior to discharge. The questionnaire 
could be completed on a tablet–computer or on the paper-pencil version. Participants were not 
provided with any compensation for their participation. 
2.3 Assessments 
The MaCS is based on the OCDS (Anton et al., 1995, 1996) and the modified German 
version of the OCDS-G (Nakovics et al., 2008), consisting of 12 items and 4 additional items, 
all of which are not substance-specific (Nakovics et al., 2009). Two items in the original 14-item 
OCDS, relating to the amount of consumption, were not included. Like the OCDS, the 12-item 
MaCS can be split into two subscales on obsessive thoughts and compulsive behavior. The 
questions pertain to enduring and recurrent thoughts about alcohol, the compulsive desire to 
consume alcohol, and loss of control over that desire. All 12 items have the same polarity, have 
five possible answers with increasing response intensity, and were coded from 0 to 4. The four 
additional items are also based on the OCDS and include three visual analogue scales related to 
average craving, maximum craving, and the frequency of craving during the last seven days. 
Finally, one item records the duration of abstinence. 
Craving was also assessed with an additional item (“Ich habe immer noch einen 
unwiderstehlichen Wunsch oder das Reissen, Alkohol zu konsumieren,” “I still have a craving 
or a strong desire to consume alcohol”) that was adapted from the DSM-5 diagnostic criterion 
for Alcohol-Related Disorders (American Psychiatric Association, 2013, p. 491). The item was 
coded with increasing intensity from 0 to 4. 
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2.4 Statistical Analysis 
The data were analyzed using the Statistical Package for the Social Sciences (SPSS) and 
the program, Analysis of Moment Structures (AMOS), version 23.0 for Windows. The MaCS 
total score was made up by the sum of the 12 items of the MaCS. Prior to analysis, the MaCS 
total score was examined for normal distribution. To explore the factor structure of the MaCS, 
exploratory factor analysis (EFA) with varimax rotation and Kaiser normalization was 
conducted. Confirmatory factor analysis (CFA) was performed to evaluate the data fit of the two 
models; the structure of the 2-factor model was guided by theory. The items and the latent 
variables were arranged according the initial model from Anton et al. (1995, 1996). A 1-factor 
model was also conducted to test the unidimensionality of the MaCS scale (Nakovics et al., 
2009). For the CFA, AMOS was used. A mock examination showed that the model did not fit 
the data well when 2 was significant (Amelang, Bartussek, Stemmler, & Hagemann, 2006). As 
fit indices, the comparative fit index (CFI) and the root mean square error of approximation 
(RMSEA) were chosen. A CFI value greater than 0.90 shows a good model fit (Amelang et al., 
2006). According to Browne and Cudeck (1992), RMSEA values <0.05 constitute good fit, 
values 0.05–0.08 acceptable fit, values 0.08–0.10 marginal fit, and values >0.10 a poor fit of the 
model. 
Internal consistency was determined through Cronbach’s alpha. Test-retest reliability 
was analyzed with two subsamples and entailed a correlation of the MaCS total score at 
admission and discharge. One sample (n = 47) had a maximum interval period of 28 days 
between admission and discharge, and the other sample (n = 24) a maximum interval period of 
10 days. To measure construct validity, correlations between the MaCS score and the 4 
additional items and the adapted DSM-5 item were obtained, and the three consumer groups 
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were compared. To compare the MaCS total scores of the three consumer groups (alcohol, licit 
drugs, and illicit drugs), a Kruskal-Wallis test was used because the conditions for a one-way 
between subjects analysis of variance (ANOVA) were not met (no normal distribution). Mann-
Whitney tests were used as post hoc tests, to follow up on this finding. A Bonferroni correction 
was applied so that all effects are reported at a .0167 level of significance. 
 
3 Results 
3.1 Item Characteristics 
The 12 items of the MaCS showed small differences in the mean and the standard 
deviation. The item discrimination power is sufficient and in a good range (Table 2). A Shapiro-
Wilk test was used to test for normality of the MaCS total score; W(155) = 0.981, p = .030 was 
non-normal, indicating that the data were not normally distributed. 
3.2 Principal Component Analysis (PCA) 
Results of the orthogonal varimax rotated PCA are presented in Table 2. The Kaiser-
Meyer-Olkin (KMO) measure verified the sampling adequacy for the analysis. KMO = .90, and 
all KMO values for individual items were >.83, which is well above the acceptable limit of .5 
(Kaiser, 1970). Bartlett’s test of sphericity 2 (66) = 926.39, p < .001, indicated that correlations 
between items were sufficiently large for PCA. According to the criterion eigenvalue >1 
(Kaiser, 1960), a 2-factor solution resulted, and the scree test (Cattell, 1966) confirmed the 2-
factor solution. The two factors collectively explained 61.74% (factor 1: 49.98%, factor 2: 
11.76%) of the variance. According to Anton et al. (1995, 1996), factor 1 could be interpreted as 
“obsessions” and factor 2 as “compulsions.” However, the loadings are not as the model 
suggested. Item 3 has a stronger loading on the second factor. Moreover, items 10 and 11 loaded 
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on the first factor, instead of the second. Moreover, it is not clear as to which factor items 9 and 
12 loaded on. The content and structure of items 3, 7, and 8 are similar. They can be interpreted 
as “interference in everyday life.” Table 2 shows the loadings for the 1-factor solution, which 
explains 48.76% of the variance. 
3.4 Confirmatory Factor Analysis (CFA) 
To examine the factor structure, two CFAs were calculated. As proposed by Anton et al. 
(1995, 1996), a model with two latent variables was evaluated, and so was a model with one 
latent variable, as proposed by Nakovics et al. (2009). Because of the above-reported PCA 
results, residuals were allowed to correlate between items 3, 7, and 8. The CFI of the two-factor 
model (Figure 1) was equal to .949 and the RMSEA was equal to .074, which supports the fit of 
the model from marginal to good. The test statistic, 2 (50) = 95.27, p < .001, indicated that the 
model and the data did not fit together well enough. The correlation between the factors was .86, 
suggesting that orthogonal independency was not met. The fit indices of the one factor model 
(Figure 2) were marginal to good (CFI = .913, RMSEA = .096) and the chi-square statistic (2 
(51) = 128.36, p < .001) significant. In terms of the chi-square test, the models did not fit the 
data, but the fit indices indicated adequate fit. 
3.5 Reliability 
At admission, internal consistency was represented by Cronbach’s  = .91, and .88 at 
discharge. The test-retest reliability for the 10-day interval was rtt = 65 and .56 for the 28-day 
interval. 
3.6 Discriminant Validity 
The MaCS total score (amount of craving) was significantly affected by the main 
substance abused, H(2) = 6.1, p < .05. There were no significant differences between alcohol 
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and licit substances (U = 1049, z = -.22, p = .416) and licit substances and drugs (U = 222, z = -
1.94, p = .026). However, when comparing alcohol with illicit substances, the MaCS total score 
was significantly lower for alcohol abusers than for illicit substance abusers (U = 1154, z = -
2.34, p = .009). 
3.7 Convergent Validity 
To assess convergent validity, the four additional items and the adapted DSM-5 item 
were correlated with the MaCS total score. The adapted DSM-5 item, which is derived from the 
DSM-5 criterion for an AUD, was moderately correlated with the MaCS total score, r = .41, p < 
.001 (for item, see page 7). The four additional items correlated highly with the MaCS (A13, r = 
.52, p < .001; A14, r = .51, p < .001; A15, r = .49, p < .001; A16, r = -.27, p = .001; for items 
A13–A16, see Table 2). 
 
4. Discussion 
The present study was designed to examine the psychometric characteristics of the 
MaCS with a Swiss German sample undergoing residential treatment for SUD. The results 
indicated that the MaCS has good psychometric characteristics and that can be used on a 
broader German-speaking population as a valid, reliable, economic (low-cost), and easy-to-use 
instrument in clinical work and research. 
According to Nakovics et al. (2009), the structure of the MaCS should be 
unidimensional. However, the theoretical background of the MaCS is the OCDS (Anton et al., 
1995, 1996), where the factor structure is not stable. Some authors found 4 factors (Bohn, 
Barton, & Barron, 1996) and others found a stable 2-factors solution (Nakovics et al., 2008). 
Similarly, the distinction between the 2 factors, “obsessions” and “compulsions,” is not clear in 
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this study. The Kaiser criterion as well as the scree plot pointed to a 2-factor solution, but the 
loading structure and the explained variance are different. There is one main factor, which 
explains almost 50% of the variance, and an additional factor, which explains a relatively small 
amount of variance (11.76%). Moreover, the first six items should load on the factor, 
“obsessions,” but item 3 loaded more strongly on the factor, “compulsions.” In addition, the 
loadings for factor 2, “compulsions,” differed for many items. Items 9 and 12 loaded almost 
equally on factor 1 and 2, although they should theoretically load on factor 2. Items 10 and 11 
clearly load on factor 1, instead of factor 2. Interestingly, Nakovics et al. (2009) found a similar 
structure, but did not discuss that result. In their study, item 3 also loaded on “compulsions” and 
not on “obsessions.” Further, items 10 to 12 loaded on the factor, “obsessions,” instead of 
“compulsions.” 
The test statistic 2 of both models of the CFA was significant, which means that the 
data did not fit the model well enough, but the fit indices for both models were in a sufficient 
range. Additionally, it was necessary to correlate the error variances of items 3, 7, and 8. The 2-
factor model had a better fit than did the 1-factor model. However, there was a high correlation 
between the two factors, suggesting that these factors are not independent from each other. 
Regarding the factor structure (PCA and CFA), this study indicates a 2-factor structure, 
in contrast to Nakovics et al. (2009). The MaCS was adapted from the OCDS, but that does not 
mean that they must have the same structure, in particular because there is no consensus about 
the exact structure of the OCDS in the research community. Further, the items of the MaCS are 
phrased unspecifically in terms of substance, enabling differences in the understanding and 
meaning of questions for participants. Another explanation could be the heterogeneous and 
unbalanced sample in terms of substances used, probably shifting the factor structure. However, 
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this is the exact intention of this questionnaire, thus making it difficult to obtain a stable factor 
structure. In future research, a sample comprising different subsamples of substances is 
necessary for the examination of the factor structure of the MaCS. 
The internal consistency (Cronbach’s alpha) of the MaCS was high. Moreover, the test-
retest reliability values were also in a good range. As expected, craving decreases during 
residential treatment (Anton et al., 1996; Demmel & Schröder, 2003), which has an impact on 
test-retest reliability (lower correlation coefficient). An important restriction using Cronbach’s 
alpha is that high internal consistency is not evidence for a homogeneous scale or even the 
unidimensionality of the scale. According to Schmitt (1996), internal consistency is certainly 
necessary, but not sufficient for homogeneity. This has to be considered when discussing the 
factor structure (see below). 
In terms of discriminant validity the lower craving level of alcohol abusers when 
compared to drug abusers was expected, with Nakovics et al. (2009) having found the same 
result. In contrast to these authors, only illicit substance abusers were compared to alcohol 
abusers in this study. Illicit substance abusers were not split into separate groups according to 
their mainly used illicit substance, because the groups would have been too small to test using 
inferential statistics. 
In terms of convergent validity, this study found lower but still significant correlation 
coefficients between the MaCS total score and the additional items, compared to those found by 
Nakovics et al. (2009). An additional indicator of convergent validity is the significant 
correlation of the MaCS total score and the adapted DSM-5 craving item. 
This study has several limitations. First, the subjects were recruited in a residential 
setting immediately after detoxification. Patients’ craving might differ from that in an outpatient 
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setting. Oslin, Cary, Slaymaker, Colleran, and Blow (2009) showed that craving decreases 
continually during inpatient treatments. Second, this study’s sample might have been selective, 
representing only substance abusers who seek residential treatment for SUD. Third, due to the 
fact that some data were not normally distributed, it was not possible to perform an ANOVA; 
thus, the Mann-Whitney test, which has a lower statistical power, was conducted. Fourth, there 
were about five times more participants in the sample with an AUD, compared to participants 
who abused licit or illicit substances, resulting in a higher distribution of AUD participants in all 
statistical tests. Thus, larger samples of patients might be necessary to cover the full range of 
SUDs. In addition, due to the relatively small groups of illicit- and licit-use disorder patients, it 
was not possible to look at every group on its own. Finally, an important factor is the construct 
of craving itself. As stated in the introduction, craving is multidimensional and the fact that the 
MaCS asks patients only about the cognitive dimension of craving does not capture 
physiological and behavioral dimensions of craving. 
Overall, the psychometric characteristics of the MaCS in a Swiss German sample are as 
good as those characteristics of the German version. This suggests that MaCS is a valid and 
reliable measure. The MaCS factor structure must be examined on a larger sample that 
integrates a broader range of SUD severity. 
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5. Conclusion for the practice 
 The MaCS has good psychometric characteristics and that can be used on a broader 
German-speaking population as a valid, reliable, economic (low-cost), and easy-to-use 
instrument in clinical work and research. 
 The MaCS is a short 12-item self-report measure for assessing the cognitive dimension 
of craving across several substances, and might facilitate naturalistic research in routine 
practice and epidemiological studies.  
 The factor structure of the MaCS suggests two dimensions; however, the exact 
“obsessions” and “compulsions” dimensions were not fully confirmed in the present 
Swiss sample. 
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Table 1 
Characteristics of the sample 
 Main substance of abuse at admission 
 
Alcohol 
n = 112 
 Licit substances 
n = 22 
 Illicit substances 
n = 18 
 M/% SD  M/% SD  M/% SD 
Age (years) 46.2 10.1  40.7 13.7  34.4 10.4 
Sex (%)         
 Men 59.8   59.1   56.2  
 Women 40.2   40.9   43.8  
Length of stay (days) 27.6 25.7  21.2 13.3  25.73 17.5 
Employment (%)         
 Full-time job 29.5   22.7   22.6  
 Part-time job 15.2   9.1   32.3  
 Unemployed 55.3   68.2   45.1  
Highest education obtained (%)         
 Middle/high school 27.2   45.5   40.0  
 Vocational education 56.3   27.3   30.0  
        (continued) 
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 Main substance of abuse at admission 
 
Alcohol 
n = 112 
 
Licit substances 
n = 22 
 
Illicit substances 
n = 18 
 M/% SD  M/% SD  M/% SD 
 University-entrance diploma 3.9   18.1   13.3  
 College/University 12.6   9.1   16.7  
Severity of the AUD (%)         
 None 1.0   21.4   30.4  
 Mild 2.0   21.4   8.7  
 Moderate 7.8   7.2   8.7  
 Severe 89.2   50.0   52.2  
 
Note. Licit substances = tobacco, benzodiazepine, and other prescribed drugs for non-medical use; 
Illicit drugs = cannabis, heroin, cocaine, LSD, ecstasy, amphetamine, and many others. AUD = Alcohol Use Disorder. 
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Table 2 
Mean (M), standard deviation (SD), item-total correlation (rit), and factor loading of the MaCS 
Item      1 factor  Rotated 2 factors  
  n M SD rit   Factor 1 Factor 2 
1 Wenn Sie keine Suchtmittel nehmen, wie viel Ihrer Zeit wird dann von 
Vorstellungen, Gedanken, Impulsen oder Bildern beansprucht, die etwas damit zu 
tun haben? 
How much of your time when you are not taking addictive drugs is occupied by 
ideas, thoughts, impulses, or images related to consume? 
154 1.61 1.22 .70 0.79  0.73 0.30 
2 Wie häufig treten diese Gedanken oder Vorstellungen auf? 
How frequently do these thoughts occur? 
155 1.32 1.19 .66 0.74  0.80 0.12 
3 Wie stark werden Ihre berufliche Tätigkeit oder Ihr soziales Verhalten von diesen 
Vorstellungen, Gedanken, Impulsen oder Bildern beeinflusst? Gibt es etwas, was 
sie deswegen nicht tun oder nicht können? 
How much do these ideas, thoughts, impulses, or images interfere with your social 
or work (or role) functioning? Is there anything that you do not or can not do 
because of them? (If you are not currently working, how much of your 
performance would be affected if you were working?) 
151 1.40 1.24 .61 0.67  0.30 0.75 
4 Wenn Sie kein Suchtmittel nehmen, wie sehr bemühen Sie sich dann, diesen 
Gedanken zu widerstehen, Sie nicht zu beachten oder Ihre Aufmerksamkeit auf 
etwas Anderes zu lenken? 
How much distress or disturbance do these ideas, thoughts, impulses, or images 
related to consuming addictive drugs cause you when you are not drinking? 
153 1.51 1.19 .75 0.80  0.69 0.41 
        (continued) 
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Item      1 factor  Rotated 2 factors  
  n M SD rit   Factor 1 Factor 2 
5 Wenn Sie kein Suchtmittel nehmen, wie sehr bemühen Sie sich dann, diesen 
Gedanken zu widerstehen, Sie nicht zu beachten oder Ihre Aufmerksamkeit auf 
etwas Anderes zu lenken? 
How much of an effort do you make to resist these thoughts or try to disregard or 
turn your attention away from these thoughts as they enter your mind when you 
are not taking addictive drugs? 
154 1.55 1.34 .64 0.71  0.76 0.14 
6 Wenn Sie kein Suchtmittel nehmen, wie erfolgreich können Sie dann diese 
Gedanken beenden oder sie zerstreuen? 
How successful are you at stopping or diverting these thoughts when you are not 
taking addictive drugs? 
155 1.48 1.21 .68 0.75  0.81 0.14 
7 Wie stark wird Ihre berufliche Tätigkeit durch die Einnahme von Suchtmitteln 
beeinflusst? Gibt es etwas, was Sie deswegen nicht tun oder nicht können? 
How much does your consumption of addictive drugs interfere with your work 
functioning? Is there anything that you do not or can not do because of your 
consumption?  
150 1.43 1.34 .56 0.61  0.16 0.87 
8 Wie stark wird Ihr soziales Verhalten durch die Einnahme von Suchtmitteln 
beeinflusst? Gibt es etwas, was Sie deswegen nicht tun oder nicht können? 
How much does your consumption of addictive drugs interfere with your social 
functioning? Is there anything that you do not or can not do because of your 
consumption? 
154 1.55 1.17 .49 0.55  0.13 0.80 
  
 
        
          
        (continued) 
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Item      1 factor  Rotated 2 factors  
  n M SD rit   Factor 1 Factor 2 
9 Wenn Sie ein Suchtmittel nehmen möchten, aber daran gehindert wären, wie 
ängstlich oder ungehalten würden Sie dann werden? 
If you were prevented from taking addictive drugs when you desired, how anxious 
or upset would you become? 
156 1.40 1.25 .63 0.70  0.53 0.47 
10 Wie sehr bemühen Sie sich der Einnahme von Suchtmittel zu widerstehen? 
How much of an effort do you make to resist consumption of addictive drugs? 
156 1.86 1.22 .56 0.64  0.65 0.17 
11 Wie stark ist Ihr Drang, Suchtmittel zu nehmen? 
How strong is the drive to consume addictive drugs? 
155 1.43 1.11 .72 0.78  0.74 0.30 
12 Wie viel Kontrolle haben Sie über Ihren Suchtmittelkonsum? 
How much control do you have over the consumption of addictive drugs? 
156 1.71 1.11 .66 0.72  0.57 0.45 
A13 Wie stark war während der letzten 7 Tage Ihr Verlangen nach Suchtmittel (der 
Wunsch danach, während der Zeit, in der sie nicht konsumierten) im Durchschnitt? 
In general, how was your craving for addictive drugs during the last 7 days (that 
is, the desire for addictive drugs while you were not taking them)? (analogue 
scale) 
155 48.84 31.44      
A14 Denken Sie bitte einmal an den Moment innerhalb der letzten 7 Tage zurück, als 
das Verlangen nach einem Suchtmittel am stärksten war. Wie stark war dieses 
Verlangen? 
Please try to remember the moment during the last 7 days when your craving for 
addictive drugs was most intense. How strong was the craving that you felt 
then?(analogue scale) 
153 58.73 34.09      
           
  
 
      (continued 
VALIDATION OF THE MANNHEIMER CRAVING SCALE (MACS)  27 
 
Item      1 factor  Rotated 2 factors  
  n M SD rit   Factor 1 Factor 2 
A15 Wie häufig hatten Sie während der letzten 7 Tage Verlangen nach einem 
Suchtmittel (den Wunsch danach, während der Zeit, in der sie nicht 
konsumierten)? 
How often during the last 7 days did you experience a craving for addictive drugs 
(that is, the desire for addictive drugs while you were not taking them)?(analogue 
scale) 
151 51.43 33.22      
A16 Wann haben Sie zuletzt ein Suchtmittel genommen? 
When did you last take addictive drugs? (days) 
143 5.96 5.82      
 
Note. Exploratory factor analysis (EFA) with varimax rotation and Kaiser normalization. 
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Figure 1. Two-factor model of the MaCS. The arrows from the latent variables to the 
manifest variables represent the standardized path coefficients. The arrows between the latent 
variables represent correlation coefficients.  
 
Abbildung 1
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Figure 2. 1-factor model of the MaCS. The arrows between the latent variables to the 
manifest variables represent the standardized path coefficients. The arrows between the latent 
variables represent correlation coefficients. 
 
Abbildung 2
